BioStem Technologies (BSEM) Stock Chart & Stock Price History $10.05 -0.30 (-2.90%) As of 08/11/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock BioStem Technologies Stock Price Performance The BioStem Technologies (BSEM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 19.60%, with a year-to-date return of -27.38%. In the past month, the stock has decreased 19.75%, reflecting recent market activity. As of the latest close, BioStem Technologies traded at $10.05 with a market cap of $168.30 million and volume of 54,426 shares. Receive BSEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.37%1 Month Performance-19.75%3 Month Performance-34.31%Year-To-Date Performance-27.38%1 Year Performance-19.60% BSEM Stock Chart for Tuesday, August, 12, 2025 BSEM Chart by TradingView BioStem Technologies Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$10.35$10.05-2.90%$10.49$9.8254,426 shs$168.30 million08/08/2025$10.40$10.35-0.48%$10.50$10.0049,797 shs$173.32 million08/07/2025$10.66$10.40-2.44%$10.60$10.2628,182 shs$174.20 million08/06/2025$10.85$10.66-1.75%$10.99$10.6522,626 shs$178.56 million08/05/2025$11.49$10.85-5.57%$11.54$10.7631,035 shs$181.69 million08/04/2025$11.26$11.49+2.02%$11.54$11.1514,023 shs$192.46 million08/01/2025$11.50$11.26-2.07%$11.97$11.0511,905 shs$188.64 million07/31/2025$11.52$11.50-0.17%$12.00$11.5021,614 shs$192.63 million07/30/2025$11.36$11.52+1.41%$11.86$11.1040,738 shs$192.91 million07/29/2025$11.25$11.36+0.98%$11.44$11.0134,523 shs$190.28 million Get the Latest News and Ratings for BSEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. 07/28/2025$11.64$11.25-3.38%$11.65$10.7122,151 shs$188.44 million07/25/2025$11.86$11.64-1.82%$12.00$11.5519,571 shs$195.04 million07/24/2025$11.06$11.86+7.23%$11.86$10.5038,430 shs$198.49 million07/23/2025$10.87$11.06+1.75%$11.20$10.5328,744 shs$185.14 million07/22/2025$10.75$10.87+1.12%$11.08$10.5223,372 shs$181.96 million07/21/2025$11.25$10.75-4.44%$11.40$10.5164,818 shs$179.96 million07/18/2025$11.50$11.25-2.17%$11.53$10.5535,299 shs$188.33 million07/17/2025$10.45$11.50+10.05%$11.50$10.5141,418 shs$192.46 million07/16/2025$10.00$10.45+4.50%$10.80$9.6591,705 shs$174.93 million07/15/2025$12.11$10.00-17.42%$12.42$9.55337,851 shs$167.36 million07/14/2025$12.52$12.11-3.31%$12.65$12.0043,821 shs$202.67 million07/11/2025$12.45$12.52+0.59%$12.65$11.9616,332 shs$209.60 million Related Companies NeoGenomics Stock Chart Niagen Bioscience Stock Chart Stoke Therapeutics Stock Chart Vir Biotechnology Stock Chart Oxford BioMedica Stock Chart Day One Biopharmaceuticals Stock Chart AnaptysBio Stock Chart Dianthus Therapeutics Stock Chart GH Research Stock Chart Zenas BioPharma Stock Chart Receive BSEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:BSEM) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access